View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
May 21, 2017

Off-label Use of Medical Devices

Any information that comes with a product is considered labelling and when the product is used for a clinical indication that is not approved, it is regarded as off-label use. Any label approved by regulatory bodies, such as the FDA, defines the clinical conditions where the product can be used and demonstrates strong and sufficient evidence with respect to the product’s safety and efficacy.

By GlobalData Healthcare

Any information that comes with a product is considered labelling and when the product is used for a clinical indication that is not approved, it is regarded as off-label use. Any label approved by regulatory bodies, such as the FDA, defines the clinical conditions where the product can be used and demonstrates strong and sufficient evidence with respect to the product’s safety and efficacy.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

In a recent US Food and Drug Administration (FDA) hearing on the off-label use of medical devices, Dr Stulting commented: “For certain populations, such as children, pregnant women, cancer patients, and patients with rare diseases, FDA sponsored clinical trials are not feasible or too costly for any manufacturer to undertake.

"This is especially true for patients with rare diseases and those with conditions that may exclude them from FDA clinical trials; for patients such as these, off-label use of medical products is our only option, one that may even be a vision or life-saving."

Off-label medical devices are more often used in the pediatric population as diseases in this group are acute and rarely chronic. Therefore, a relatively small patient population is available for enrollment into clinical trials, limiting research and development (R&D) of approved devices. In some cases, the off-label use of a device is considered as medical standard-of-care. Common pediatric off-label applications include dilation balloons for pulmonary artery stenosis and valvar aortic stenosis, cutting balloons for pulmonary artery stenosis and creation of atrial septal defect, and radiofrequency perforation wire for perforation of atretic pulmonary valve.

Uni-elbow arthroplasty (partial elbow replacement) is one of the FDA approved off-label substitute products for the capitellum and radial head. This suffices unmet needs of damaged capitellum when the radial head is fine and functional. However, this product was approved for complete replacement, whereas the off-label usage aids in partial and essential replacement of damaged compartments.

While the off-label use of medical devices has become a common practice, the devices may have drawbacks, which include patient safety, lack of entrepreneurial development, and educational support. The impetus for industry entrepreneurial advancement of pediatric-specific devices is limited as the standard-of-care in various situations has become the off-label use of approved devices.

In general, in three to seven years, around $1 million to $10 million is estimated to be invested in conducting clinical trials designed for FDA approval of medical devices. If off-label usage of devices gets approved by the regulatory authorities, time and cost incurred in clinical trials can be reduced.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network